Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study.
Mohammad Haji AghajaniOmid MoradiHamed Azhdari TehraniHossein AminiElham PourheidarFirouze HatamiMohammad Mahdi RabieiMohammad SistanizdPublished in: International journal of clinical practice (2021)
Atorvastatin add-on therapy in patient with severe COVID-19 was associated with lower in-hospital mortality and reduced the risk of need for invasive mechanical ventilation which supports to continue the prescription of the medication.
Keyphrases
- mechanical ventilation
- coronavirus disease
- acute respiratory distress syndrome
- sars cov
- intensive care unit
- respiratory failure
- early onset
- extracorporeal membrane oxygenation
- healthcare
- cardiovascular events
- respiratory syndrome coronavirus
- emergency department
- stem cells
- cardiovascular disease
- coronary artery disease
- drug induced
- adverse drug
- type diabetes